EP0775155 - ESTRA-1,3,5(10)-TRIENE DERIVATIVES, METHODS OF PREPARING SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 11.03.2005 Database last updated on 09.09.2024 | Most recent event Tooltip | 19.09.2008 | Change - representative | published on 22.10.2008 [2008/43] | Applicant(s) | For all designated states Schering AG Müllerstrasse 178 13353 Berlin / DE | [2003/40] |
Former [1997/35] | For all designated states Jenapharm GmbH & Co. KG Otto-Schott-Strasse 15 07745 Jena / DE | ||
Former [1997/22] | For all designated states JENAPHARM GmbH Otto-Schott-Strasse 15 D-07745 Jena / DE | Inventor(s) | 01 /
SIEMANN, Hans-Joachim - verstorben / DE | 02 /
SCHWARZ, Sigfrid Ottogerd-Mühlmann-Strasse 17 D-07743 Jena / DE | 03 /
ELGER, Walter Schorlemerallee 12b D-14195 Berlin / DE | 04 /
REDDERSEN, Gudrun Hügelstrasse 25 D-07749 Jena / DE | 05 /
SCHNEIDER, Birgitt Damaschkeweg 19 D-07745 Jena / DE | [1997/22] | Representative(s) | Ziebig, Marlene, et al Gulde Hengelhaupt Ziebig & Schneider Wallstraße 58/59 DE-10179 Berlin / DE | [N/P] |
Former [2008/43] | Ziebig, Marlene, et al Gulde Hengelhaupt Ziebig & Schneider Patentanwälte Rechtsanwälte Wallstrasse 58/59 10179 Berlin / DE | ||
Former [2003/31] | Ziebig, Marlene K., Dr., et al Anwaltskanzlei, Gulde Hengelhaupt Ziebig & Schneider, Schützenstrasse 15-17 10117 Berlin / DE | ||
Former [2003/25] | Rasch, Dorit, et al c/o Anwaltskanzlei, Gulde Hengelhaupt Ziebig & Schneider, Schützenstrasse 15-17 10117 Berlin / DE | ||
Former [1997/22] | Wablat, Wolfgang, Dr.Dr. Patentanwalt, Dr. Dr. W. Wablat, Potsdamer Chaussee 48 14129 Berlin / DE | Application number, filing date | 95925679.3 | 03.07.1995 | [1997/22] | WO1995DE00877 | Priority number, date | DE19944429397 | 09.08.1994 Original published format: DE 4429397 | [1997/22] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO9605216 | Date: | 22.02.1996 | Language: | DE | [1996/09] | Type: | A1 Application with search report | No.: | EP0775155 | Date: | 28.05.1997 | Language: | DE | The application published by WIPO in one of the EPO official languages on 22.02.1996 takes the place of the publication of the European patent application. | [1997/22] | Type: | B1 Patent specification | No.: | EP0775155 | Date: | 06.05.2004 | Language: | DE | [2004/19] | Search report(s) | International search report - published on: | EP | 22.02.1996 | Classification | IPC: | C07J41/00, A61K31/56, C07J53/00, C07J43/00 | [1997/22] | CPC: |
C07J43/003 (EP,US);
A61P15/00 (EP);
A61P15/18 (EP);
A61P5/24 (EP);
A61P5/26 (EP);
A61P5/30 (EP);
A61P5/34 (EP);
C07J41/0072 (EP,US);
C07J51/00 (EP,US);
C07J53/004 (EP,US)
(-)
| Designated contracting states | AT, BE, CH, DE, DK, ES, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [1997/22] | Title | German: | ESTRA-1,3,5(10)-TRIEN-DERIVATE, VERFAHREN ZU IHRER HERSTELLUNG UND DIESE VERBINDUNGEN ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN | [1997/22] | English: | ESTRA-1,3,5(10)-TRIENE DERIVATIVES, METHODS OF PREPARING SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | [1997/22] | French: | DERIVES ESTRA-1,3,5(10)-TRIENE, LEURS PROCEDES DE PREPARATION ET COMPOSITIONS PHARMACEUTIQUES LES CONTENANT | [1997/22] | Entry into regional phase | 20.01.1997 | National basic fee paid | 20.01.1997 | Designation fee(s) paid | 20.01.1997 | Examination fee paid | Examination procedure | 19.12.1995 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 20.01.1997 | Examination requested [1997/22] | 03.06.1997 | Despatch of a communication from the examining division (Time limit: M08) | 02.02.1998 | Reply to a communication from the examining division | 27.05.1999 | Despatch of a communication from the examining division (Time limit: M02) | 27.07.1999 | Reply to a communication from the examining division | 12.04.2000 | Despatch of a communication from the examining division (Time limit: M06) | 22.08.2000 | Reply to a communication from the examining division | 05.10.2001 | Despatch of a communication from the examining division (Time limit: M04) | 11.02.2002 | Reply to a communication from the examining division | 15.05.2003 | Communication of intention to grant the patent | 17.11.2003 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time | 16.01.2004 | Fee for grant paid | 16.01.2004 | Fee for publishing/printing paid | Divisional application(s) | EP02090252.4 / EP1284273 | EP02090253.2 / EP1273590 | Opposition(s) | 08.02.2005 | No opposition filed within time limit [2005/17] | Request for further processing for: | 16.01.2004 | Request for further processing filed | 16.01.2004 | Full payment received (date of receipt of payment) Request granted | 09.03.2004 | Decision despatched | Fees paid | Renewal fee | 02.06.1997 | Renewal fee patent year 03 | 16.04.1998 | Renewal fee patent year 04 | 22.04.1999 | Renewal fee patent year 05 | 26.06.2000 | Renewal fee patent year 06 | 19.06.2001 | Renewal fee patent year 07 | 17.06.2002 | Renewal fee patent year 08 | 13.06.2003 | Renewal fee patent year 09 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | GR | 06.08.2004 | [2005/06] | Cited in | International search | [XY]DE1949095 (JENAPHARM VEB) [X] 1,3,4 * page 3, line 9 - line 18; examples 27-29 * [Y] 1-4; | [XY]FR2133484 (JENAPHARM VEB [DD]) [X] 1,3,4 * page 2, line 14 - line 18; examples 21-23,25,27 * [Y] 1-4; | [X]GB1317373 (JENAPHARM VEB) [X] 1,3,4 * examples 11-14,16 *; | [X]GB1398026 (JENAPHARM VEB) [X] 1,3,4 * examples 2,4-6,18; claim 31 *; | [XY]DD114806 (S. SCHWARTZ) [X] 1,3,4 * page 2, column 1, line 52 - line 59; examples 2-4,6,9,10 * [Y] 1-4; | [Y]FR2429797 (JENAPHARM VEB [DD]) [Y] 1-4 * page 1, line 21 - line 33; examples 2,4,7 *; | [XY]DD201143 (SCHWARZ SIGFRID, et al) [X] 1,3,4 * page 1, lines 6-8; examples 3-5 * [Y] 1-4; | [XY]DD207447 (JENAPHARM VEB [DD]) [X] 1,3,4 * examples 1-5 * [Y] 1-4; | [Y]EP0430386 (SCHERING AG [DE]) [Y] 1-4 * the whole document *; | [Y]WO9401450 (SCHERING AG [DE], et al) [Y] 1-4* the whole document * | [XY] - SCHWARZ S ET AL, "Steroids. XI. 17.alpha.-Ethynylestradiol sulfamates", Z. CHEM., vol. 10, no. 8, pages 299 - 300 [X] 1,3,4 * the whole document * [Y] 1-4 | [XY] - SCHWARZ S ET AL, "Steroids. 15. Sulfonyloxy derivatives of estrogens", PHARMAZIE, BERLIN DE, vol. 30, no. 1, pages 17 - 21 [X] 1,3,4 * siehe verbindungen 18-25, 28-32, 59-62, 80, 81 und 110-113 * [Y] 1-4 | [XY] - STOELZNER W ET AL, "Dissociation of the antigonadotrophic and the contraceptive activities of certain estratriene derivatives", PHARMAZIE, BERLIN DE, vol. 30, no. 1, pages 52 - 53 [X] 1,3,4 * the whole document * [Y] 1-4 | [XY] - SHU H D ET AL, "Structure-activity relationships of estradiol derivatives", CHEMICAL ABSTRACTS, (19791217), vol. 091, no. 25, Database accession no. 204845, page 97, column 2 [X] 1,3,4 * abstract * [Y] 1-4 | [ ] - YAO HSUEH HSUEH PAO, 1ST MED. COLL. SHANGHAI;DEP. PHARMACOL.; SHANGHAI; PEOP. R. CHINA, vol. 14, no. 6, pages 343 - 348 | [X] - HOWARTH N M ET AL, "Estrone sulfamates: potent inhibitors of estrone sulfatase with therapeutic potential", JOURNAL OF MEDICINAL CHEMISTRY, WASHINGTON US, (19940121), vol. 37, no. 2, pages 219 - 221 [X] 1,3,4 * page 219; examples 4-6 * | [Y] - J. KALVODA ET AL, "7-alpha-Methylöstrogene", HELVETICA CHIMICA ACTA, BASEL CH, vol. 50, no. 1, pages 281 - 288 [Y] 1-4 * page 282 - page 283; examples V,IX,XI,XV * | [Y] - N. UBEROI ET AL, "Structure Activity Reltionships of some Unique Estrogens Related to Estradiol Are Predicted by Fit into DNA", STEROIDS, SAN FRANCISCO US, vol. 45, no. 3-4, pages 325 - 340 [Y] 1-4 * page 325 - page 334 * | [Y] - R. PETERS ET AL, "17-Desoxy Estrogen Analogues", JOURNAL OF MEDICINAL CHEMISTRY, WASHINGTON US, vol. 32, no. 7, pages 1642 - 1652 [Y] 1-4 * page 1646; table II * | [Y] - B. BHAVNANI ET AL, "Interaction of Ring-B Unsaturated Estrogens with Estrogen Receptors of Human Endometrium and Rat Uterus", STEROIDS: STRUCTURE, FUNCTION, AND REGULATION, MA US, vol. 56, no. 4, pages 201 - 210 [Y] 1-4 * the whole document * |